Aktienanalyse zu Pulsenmore Ltd (PLSM)PLSMPulsenmore Ltd

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products. It operates in the Healthcare sector.

Pulsenmore Ltd is not a good buy right now. The current price is $1.51, which is significantly down 84.02% year-to-date. The RSI is at 25.769, indicating that the stock is oversold, but this could also suggest continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the stock has a 52-week high of $12.97, showing a large gap from the current price. The main risk is the negative sentiment reflected in the 5-day change of -9.57% and the ongoing volatility in the stock's performance.